FI940307A0 - Kiraalivälituotteet antidiabettisten tiatsolien valmistamiseksi - Google Patents

Kiraalivälituotteet antidiabettisten tiatsolien valmistamiseksi

Info

Publication number
FI940307A0
FI940307A0 FI940307A FI940307A FI940307A0 FI 940307 A0 FI940307 A0 FI 940307A0 FI 940307 A FI940307 A FI 940307A FI 940307 A FI940307 A FI 940307A FI 940307 A0 FI940307 A0 FI 940307A0
Authority
FI
Finland
Prior art keywords
thiazoles
antidiabetic
preparation
chiral intermediates
chiral
Prior art date
Application number
FI940307A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI940307A (fi
Inventor
George J Quallich
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI940307A0 publication Critical patent/FI940307A0/fi
Publication of FI940307A publication Critical patent/FI940307A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI940307A 1991-07-22 1994-01-21 Kiraalivälituotteet antidiabettisten tiatsolien valmistamiseksi FI940307A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73354891A 1991-07-22 1991-07-22
PCT/US1992/005434 WO1993002061A1 (en) 1991-07-22 1992-07-01 Chiral intermediates for the preparation of antidiabetics thiazoles

Publications (2)

Publication Number Publication Date
FI940307A0 true FI940307A0 (fi) 1994-01-21
FI940307A FI940307A (fi) 1994-01-21

Family

ID=24948077

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940307A FI940307A (fi) 1991-07-22 1994-01-21 Kiraalivälituotteet antidiabettisten tiatsolien valmistamiseksi

Country Status (17)

Country Link
US (1) US5576442A (es)
EP (1) EP0641331A1 (es)
JP (1) JP2672029B2 (es)
KR (1) KR100214907B1 (es)
AU (1) AU660187B2 (es)
CA (1) CA2111446C (es)
FI (1) FI940307A (es)
HU (1) HUT70422A (es)
IE (1) IE922358A1 (es)
IL (1) IL102575A (es)
MX (1) MX9204277A (es)
NO (1) NO940226D0 (es)
NZ (1) NZ243652A (es)
PT (1) PT100709B (es)
TW (1) TW199892B (es)
WO (1) WO1993002061A1 (es)
ZA (1) ZA925470B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687149B1 (fr) * 1992-02-12 1995-11-03 Roussel Uclaf Nouveaux esters pyrethrinouides derives d'alcools thiazoliques, leur procede de preparation et leur application comme pesticides.
EP0708764A1 (en) * 1993-07-16 1996-05-01 Pfizer Inc. Enanthioselective preparation of thiazole derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3621775A1 (de) * 1986-03-13 1988-01-07 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US4886814A (en) * 1986-03-13 1989-12-12 Dr. Karl Thomas Gmbh Substituted thiazoles and oxazoles and 2-hydroxy-morpholines
US4943635A (en) * 1987-08-27 1990-07-24 President & Fellows Of Harvard College Enantioselective reduction of ketones
US5036079A (en) * 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
EP0595868B1 (en) * 1991-07-22 1998-11-25 Pfizer Inc. Process for the preparation of (s)-4-[3-(5-methyl-2-phenyl-4-oxazolyl)- 1-hydroxypropyl]bromobenzene

Also Published As

Publication number Publication date
IL102575A0 (en) 1993-01-14
IL102575A (en) 1996-03-31
PT100709A (pt) 1993-09-30
FI940307A (fi) 1994-01-21
NZ243652A (en) 1994-02-25
JPH06505026A (ja) 1994-06-09
ZA925470B (en) 1994-01-21
CA2111446C (en) 1997-12-16
WO1993002061A1 (en) 1993-02-04
NO940226L (no) 1994-01-21
EP0641331A1 (en) 1995-03-08
US5576442A (en) 1996-11-19
MX9204277A (es) 1993-02-01
KR100214907B1 (ko) 1999-08-02
TW199892B (es) 1993-02-11
IE922358A1 (en) 1993-01-27
AU660187B2 (en) 1995-06-15
HU9400187D0 (en) 1994-05-30
HUT70422A (en) 1995-10-30
JP2672029B2 (ja) 1997-11-05
AU2306392A (en) 1993-02-23
PT100709B (pt) 1999-07-30
NO940226D0 (no) 1994-01-21
CA2111446A1 (en) 1993-02-04

Similar Documents

Publication Publication Date Title
FI954768A (fi) Välituotteina käyttökelpoiset 4-syklopropyylimetoksipyridiiniyhdisteet
FI962599A0 (fi) Enantioselektiivinen menetelmä kiraalisten triaryylijohdannaisten ja niiden valmistuksessa käytettävien kiraalisten välituotteiden valmistamiseksi
FI940769A0 (fi) Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi
FI103666B1 (fi) Menetelmä bifenyylijohdannaisen valmistamiseksi
FI942907A (fi) Menetelmä lipaasin valmistamiseksi
FI952585A0 (fi) Menetelmä bentsopyraaniyhdisteiden valmistamiseksi
FI954272A0 (fi) Menetelmä akryylipiperidiinikarbinolien valmistamiseksi
FI960254A (fi) Menetelmä N-(4-hydroksifenyyli)-retiiniamidin valmistamiseksi
FI893003A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI902316A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia substituoituja dihydropyrrolitsiiniyhdisteitä
EE9400257A (et) Kinoliin-3-karboksamiidi ühendi kasutamine ravimkompositsiooni valmistamiseks
FI98461B (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
BR9206293A (pt) Tiazolidinadionas hipoglicêmicas e intermediários
FI911701A (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi
FI940307A0 (fi) Kiraalivälituotteet antidiabettisten tiatsolien valmistamiseksi
FI892144A (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
FI102841B1 (fi) Menetelmä mannitolin valmistamiseksi
FI972694A0 (fi) Uusi menetelmä sameridiinin valmistamiseksi
FI940551A (fi) Menetelmä fenyylibentsamidijohdannaisten valmistamiseksi
FI971964A0 (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
FI951441A (fi) Menetelmä 5-formyyliamino-pyrimidiinien valmistamiseksi
DE59309038D1 (de) Chlorthiazolderivate
FI964117A0 (fi) Menetelmä uusien 1-asyylipiperidiiniyhdisteiden valmistamiseksi
FI960180A0 (fi) Tiatsolijohdannaisten enantioselektiivinen valmistus
NO177592C (no) Nye mellomprodukter for fremstilling av carbapenemderivater